Harmony Biosciences Holdings, Inc.

NasdaqGM:HRMY Stock Report

Market Cap: US$1.7b

Harmony Biosciences Holdings Future Growth

Future criteria checks 4/6

Harmony Biosciences Holdings is forecast to grow earnings and revenue by 25.8% and 16.3% per annum respectively while EPS is expected to grow by 25.8% per annum.

Key information

25.7%

Earnings growth rate

25.7%

EPS growth rate

Pharmaceuticals earnings growth21.0%
Revenue growth rate16.2%
Future return on equityn/a
Analyst coverage

Good

Last updated19 Apr 2024

Recent future growth updates

Recent updates

These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely

Apr 04
These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely

Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings

Feb 09
Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings

Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Mar 21
Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?

Dec 01
Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?

Harmony Biosciences: In Harmony

Sep 23

We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease

Aug 05
We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease

Harmony Biosciences Non-GAAP EPS of $0.57 misses by $0.06, revenue of $107M beats by $6.25M

Aug 02

Harmony Biosciences: Steady Revenue Generator Looking For A Future

May 26

Harmony Biosciences: Strong Growth At A Reasonable Price

Mar 04

Our First Look At Harmony Biosciences

Nov 04

Harmony Biosciences Holdings' (NASDAQ:HRMY) Promising Earnings May Rest On Soft Foundations

Aug 17
Harmony Biosciences Holdings' (NASDAQ:HRMY) Promising Earnings May Rest On Soft Foundations

Harmony Biosciences Is Likely To Trade Higher As Wakix Sales Build

Jul 13

Harmony Bio reports clinical impact of Wakix in excessive daytime sleepiness at SLEEP 2021

Jun 10

Earnings and Revenue Growth Forecasts

NasdaqGM:HRMY - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20269813033333846
12/31/20258402442813147
12/31/20247121832032838
12/31/2023582129219219N/A
9/30/2023542151169169N/A
6/30/2023499200161162N/A
3/31/2023472189158158N/A
12/31/2022438181104144N/A
9/30/2022401156115155N/A
6/30/20223645890131N/A
3/31/20223314975115N/A
12/31/202130535-299N/A
9/30/202127112-3171N/A
6/30/202123517-5349N/A
3/31/2021200-7-6636N/A
12/31/2020160-64-5-3N/A
9/30/2020109-110-114-37N/A
6/30/202064-146-146-69N/A
3/31/202026-165-169-92N/A
12/31/20196-187-203-75N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HRMY's forecast earnings growth (25.8% per year) is above the savings rate (2.3%).

Earnings vs Market: HRMY's earnings (25.8% per year) are forecast to grow faster than the US market (14.6% per year).

High Growth Earnings: HRMY's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HRMY's revenue (16.3% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: HRMY's revenue (16.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if HRMY's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.